Bond.az White LogoBond.az Black Logo

Nvidia Launches Vera CPU for AI Agent Workloads

Nvidia launches Vera CPU for AI agent workloads. 88-core processor offers 1.8x speed over x86. Partners include Anthropic, OpenAI, Dell, HPE, and more.

Grace Lewis
ByGrace Lewis- Senior Editor
|
0

TAIPEI - Nvidia Corp. (NASDAQ:NVDA) announced Saturday the launch of its Vera CPU, designed for artificial intelligence agent workloads, with full production now underway. The $5.11 trillion semiconductor giant continues to expand its product portfolio beyond GPUs as it solidifies its position in the industry.

The company stated the processor delivers 1.8x faster task completion compared with x86 CPUs for workloads including agentic AI, reinforcement learning and data processing. The chip features 88 Olympus cores and an LPDDR5X memory subsystem providing up to 1.2TB/s of bandwidth.

Vera serves as the CPU for standalone Vera servers, Nvidia Vera Rubin systems and Vera BlueField-4 STX AI storage platforms. The processor connects to GPUs through second-generation NVLink-C2C interconnect technology, offering up to 1.8TB/s of coherent bandwidth between CPU and GPU.

Organizations planning to adopt Vera include Anthropic, OpenAI, SpaceXAI, ByteDance, CoreWeave and Oracle Cloud Infrastructure. NYSE stated it will use Vera CPUs in collaboration with Redpanda and HPE to scale capacity while optimizing latency for its market infrastructure, which processes over 1.1 trillion messages daily.

The Vera launch comes as Nvidia maintains exceptional financial performance, with revenue growth of 71% over the last twelve months and a return on assets of 83%. According to Bond.az analysis, the stock currently trades below its Fair Value.

"Scaling compute is an important accelerant for the growth of models," said James Bradbury, head of compute at Anthropic. "We're excited to see Vera emerge as a promising part of the ecosystem when solving for agentic workloads."

System manufacturers building Vera CPU systems include Dell Technologies, HPE, Lenovo and Supermicro, along with ASUS, Compal, Foxconn, GIGABYTE, Pegatron, Quanta Cloud Technology, Wistron and Wiwynn. Nvidia reported nearly 2.5 million shipments of its Grace CPUs to date. Vera systems will be available from system builders and cloud partners starting this fall.

Cloud service providers planning to deploy Vera CPUs include Akamai, Cloudflare, Lambda, Nebius, Nscale and Together AI.

More News
Today / 05:33
|
810

Genentech to Present Obesity Drug Trial Data at ADA

Genentech presents Phase II data for obesity drugs enicepatide and petrelintide at ADA conference. Latest updates on weight loss treatments.

0
Today / 04:33
|
605

Nvidia Vera Rubin platform enters full production

Nvidia's Vera Rubin platform enters full production for AI systems, with global supply chain partners ramping up manufacturing.

0
Yesterday / 21:00
|
243

Berkshire Hathaway buys Taylor Morrison for $8.5B

Berkshire Hathaway acquires Taylor Morrison for $8.5 billion. The deal is expected to close in H2 2026.

0
Yesterday / 16:31
|
665

iHuman acquires two education apps for $13M

iHuman Inc. acquires All Knowledge and Perfect Lingo education apps for RMB94 million, appoints new executives.

0
Yesterday / 13:02
|
563

Revolution Medicines Phase 3 Trial Results

Revolution Medicines announces positive Phase 3 trial results for daraxonrasib in pancreatic cancer, showing significant survival benefit.

0
Yesterday / 13:01
|
802

Prostate cancer death risk cut by 20% with J&J drug

Johnson & Johnson's apalutamide reduces prostate cancer death risk by 20%, according to Phase 3 trial results.

0
Yesterday / 12:31
|
392

Brenetafusp Shows Promise in Melanoma

Immunocore's brenetafusp showed 14.3-month median overall survival in Phase 1/2 melanoma trial, supporting Phase 3 development.

0
Yesterday / 09:32
|
612

National Vision Q1 2026: margins expand

National Vision Holdings Q1 2026 financial results: revenue $543.9M, margin expansion, 4.5% comparable store sales growth.

0
2026-05-30 15:31
|
753

Mineralys Presents Lorundrostat Data in Kidney Patients

Mineralys (MLYS) reveals new clinical data for lorundrostat showing efficacy in hypertensive patients with chronic kidney disease.

0
2026-05-30 14:31
|
541

Cabometyx Cuts Neuroendocrine Tumor Risk

Exelixis announces Cabometyx reduces neuroendocrine tumor progression risk by 74% in CABINET trial. New data presented at ASCO.

0
2026-05-30 12:32
|
339

Immunome presents phase 3 trial results for desmoid tumor drug

Immunome announces phase 3 results for varegacestat in desmoid tumors: 84% reduction in progression risk, 56% objective response rate.

0
2026-05-30 07:30
|
735

Tesla Faces China Lawsuit Over Full Self-Driving Claims

Tesla faces a consumer lawsuit in China over Full Self-Driving claims. 10 vehicle owners allege misleading advertising and fraud, seeking $583,000 in damages.

0
...
Nvidia Launches Vera CPU for AI Agent Workloads | Bond.az